The two most common agents include subcutaneous semaglutide (Ozempic, approved for type 2 diabetes, and Wegovy, approved for weight loss) and liraglutide (Saxenda, approved for weight loss, and Victoza, approved for type 2 diabetes), though an oral formulation of semaglutide is available (Rybelsus)
Set a reminder to take your antioxidant stack 20 minutes before breakfast
doi:10.1016/j.jid.2023.09.276
This blog breaks down the distinct roles of each hormone, why some patients respond better than others, and how clinicians can support these pathways using both pharmaceutical and nutraceutical strategies including tools available now, like SLM+
Ask your provider why those ingredients are included and whether they serve a clinical purpose for your specific situation